Total Payments
$266,218
2024 Payments
$37,660
Companies
37
Transactions
804
Medicare Patients
7,680
Medicare Billing
$960,757
Payment Breakdown by Category
Other$225,558 (84.7%)
Food & Beverage$28,937 (10.9%)
Travel$11,393 (4.3%)
Consulting$300.00 (0.1%)
Education$29.15 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $225,059 | 137 | 84.5% |
| Food and Beverage | $28,937 | 593 | 10.9% |
| Travel and Lodging | $11,393 | 69 | 4.3% |
| Honoraria | $500.00 | 1 | 0.2% |
| Consulting Fee | $300.00 | 1 | 0.1% |
| Education | $29.15 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $231,141 | 332 | $0 (2024) |
| BIOTRONIK INC. | $14,181 | 173 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $7,182 | 34 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $2,168 | 11 | $0 (2022) |
| ATRICURE, INC. | $1,674 | 10 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,434 | 15 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $1,362 | 31 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,029 | 28 | $0 (2024) |
| Janssen Research & Development, LLC | $868.11 | 9 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $642.24 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37,660 | 145 | Janssen Pharmaceuticals, Inc ($26,133) |
| 2023 | $12,458 | 94 | Janssen Pharmaceuticals, Inc ($9,610) |
| 2022 | $45,581 | 97 | Janssen Pharmaceuticals, Inc ($41,608) |
| 2021 | $23,247 | 82 | Janssen Pharmaceuticals, Inc ($21,616) |
| 2020 | $15,609 | 84 | Janssen Pharmaceuticals, Inc ($13,418) |
| 2019 | $58,597 | 116 | Janssen Pharmaceuticals, Inc ($55,721) |
| 2018 | $40,959 | 110 | Janssen Pharmaceuticals, Inc ($34,822) |
| 2017 | $32,107 | 76 | Janssen Pharmaceuticals, Inc ($28,214) |
All Payment Transactions
804 individual payment records from CMS Open Payments — Page 2 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $28.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.46 | General |
| Category: Cardiovascular | ||||||
| 09/30/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Education | In-kind items and services | $9.09 | General |
| Category: Cardiovascular | ||||||
| 09/28/2024 | Medtronic, Inc. | AZURE XT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Pacemakers | ||||||
| 09/27/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,605.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $32.73 | General |
| Category: Cardiology | ||||||
| 09/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Respiratory | ||||||
| 09/21/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Travel and Lodging | In-kind items and services | $337.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/21/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $102.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/21/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $85.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/21/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $42.69 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/17/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/10/2024 | Medtronic, Inc. | COBALT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/05/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device) | Food and Beverage | In-kind items and services | $58.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Cardiology | ||||||
| 08/22/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device), ISOLATOR SURGICAL ABLATION SYSTEM, ATRICLIP LAA EXCLUSION SYSTEM | Travel and Lodging | In-kind items and services | $557.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $29.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: DIABETES | ||||||
| 08/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,018 | 3,495 | $432,722 | $172,600 |
| 2022 | 27 | 2,133 | 3,746 | $653,508 | $270,634 |
| 2021 | 24 | 1,742 | 3,084 | $609,116 | $264,131 |
| 2020 | 30 | 1,787 | 3,068 | $625,948 | $253,392 |
Total Patients
7,680
Total Services
13,393
Medicare Billing
$960,757
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 32 | 33 | $53,147 | $25,973 | 48.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 201 | $32,535 | $22,743 | 69.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 223 | $26,253 | $17,928 | 68.3% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 29 | 238 | $75,307 | $15,403 | 20.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 164 | 165 | $31,515 | $9,463 | 30.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 750 | 1,082 | $24,886 | $7,887 | 31.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 40 | 40 | $31,250 | $7,386 | 23.6% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 14 | 14 | $21,365 | $7,153 | 33.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 57 | 59 | $22,479 | $7,116 | 31.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 32 | 32 | $9,505 | $5,704 | 60.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 34 | 75 | $8,110 | $5,557 | 68.5% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 24 | 25 | $8,268 | $5,460 | 66.0% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 82 | 243 | $12,654 | $5,253 | 41.5% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 64 | 186 | $11,118 | $4,964 | 44.6% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 22 | 186 | $8,693 | $4,284 | 49.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 50 | $11,500 | $3,631 | 31.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 93 | 236 | $6,189 | $3,201 | 51.7% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 22 | 70 | $5,622 | $2,257 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 25 | 29 | $8,207 | $2,247 | 27.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $5,696 | $2,057 | 36.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $3,191 | $2,053 | 64.3% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 11 | 11 | $3,916 | $1,230 | 31.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 34 | 35 | $2,450 | $766.15 | 31.3% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 33 | 33 | $1,371 | $763.29 | 55.7% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 39 | 39 | $1,989 | $594.22 | 29.9% |
About Dr. George Juang, MD
Dr. George Juang, MD is a Specialist healthcare provider based in Flushing, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1003802547.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Juang, MD has received a total of $266,218 in payments from pharmaceutical and medical device companies, with $37,660 received in 2024. These payments were reported across 804 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($225,059).
As a Medicare-enrolled provider, Juang has provided services to 7,680 Medicare beneficiaries, totaling 13,393 services with total Medicare billing of $960,757. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Cardiovascular Disease, Clinical Cardiac Electrophysiology
- Location Flushing, NY
- Active Since 09/20/2005
- Last Updated 06/16/2018
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1003802547
Products in Payments
- XARELTO (Drug) $231,073
- MULTAQ (Drug) $7,182
- VersaCross Access Solution (Device) $2,137
- ENTRESTO (Drug) $1,327
- SYNERGY ABLATION SYSTEM (Device) $1,125
- VERQUVO (Drug) $912.70
- Acticor 7 VR-T DX (Device) $720.44
- Edora 8 DR-T (Device) $612.12
- Micra (Device) $610.46
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $548.69
- BIOMONITOR (Device) $526.51
- Sotalol Hydrochloride (Drug) $500.00
- LifeVest (Device) $432.40
- BioMonitor (Device) $382.35
- Assure WCD (Device) $365.82
- Repatha (Biological) $344.99
- Solia (Device) $338.02
- Rivacor (Device) $335.58
- SelectSecure (Device) $290.41
- AIRSUPRA (Drug) $255.79
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Flushing
Daniel Skupski, Md, MD
Specialist — Payments: $16,957
Specialist $16,957
Dr. Zeyar Thet, Md, MD
Specialist — Payments: $15,422
Specialist $15,422
Meyer Gershbaum, Md, MD
Specialist — Payments: $15,197
Specialist $15,197
Dr. June Yin, Md, MD
Specialist — Payments: $10,590
Specialist $10,590
Dr. Helen Hsieh
Specialist — Payments: $9,560
Specialist $9,560
King-Chen Hon, M.d, M.D
Specialist — Payments: $5,249
Specialist $5,249